Literature DB >> 19389003

Longitudinal studies of time-dependent changes in both bladder and erectile function after streptozotocin-induced diabetes in Fischer 344 male rats.

Arnold Melman1, Elena Zotova, Mimi Kim, Joseph Arezzo, Kelvin Davies, Michael DiSanto, Moses Tar.   

Abstract

OBJECTIVES: To provide sensitive physiological endpoints for the onset and long-term progression of deficits induced by diabetes mellitus (DM) in bladder and erectile function in male rats, and to evaluate parallel changes in urogenital and nerve function induced by hyperglycaemia over a protracted period as a model for chronic deficits in patients with diabetes.
MATERIALS AND METHODS: The study comprised in 877 male, 3-month-old, Fischer 344 rats; 666 were injected intraperitoneally with 35 mg/kg streptozotocin (STZ) and divided into insulin-treated and untreated diabetic groups. The rats were studied over 8 months and measurements made of both erectile and bladder function, as well as nerve conduction studies over the duration of the study.
RESULTS: There was an early (first month) abnormality of both erectile and bladder function that persisted through the 8 months of the study. The erectile dysfunction was manifest as reduced intracavernous pressure/blood pressure ratio, and the bladder dysfunction as a persistent increase in detrusor overactivity with no detrusor decompensation. Insulin treatment prevented or modified the abnormality in each organ. Hyperglycaemia caused a progressive decrease in caudal nerve conduction velocity. The mean digital sensory and tibial motor nerve conduction velocity did not deteriorate over time. Correlation measurements of nerve and organ function were not consistent.
CONCLUSIONS: The results of this extensive long-term study show early and profound effects of hyperglycaemia on the smooth muscle of the penis and bladder, that were persistent and stable in surviving rats over the 8 months. The physiological changes did not correlate well with neurological measurements of those organs. Significantly, diverse smooth-muscle cellular and subcellular events antedated the measured neurological manifestations of the hyperglycaemia by several months. Although autonomic diabetic neuropathy is a primary life-threatening complication of long-term diabetes in humans, this rat model of STZ-induced diabetes showed that the rapid onset of physiological manifestations was based on many molecular changes in the smooth muscle cells in this model of type 1 DM.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19389003     DOI: 10.1111/j.1464-410X.2009.08573.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  12 in total

1.  Oxidative stress status accompanying diabetic bladder cystopathy results in the activation of protein degradation pathways.

Authors:  Nirmala D Kanika; Jinsook Chang; Yuehong Tong; Scott Tiplitsky; Juan Lin; Elizabeth Yohannes; Moses Tar; Mark Chance; George J Christ; Arnold Melman; Kelvin D Davies
Journal:  BJU Int       Date:  2010-09-21       Impact factor: 5.588

2.  Novel insights into development of diabetic bladder disorder provided by metabolomic analysis of the rat nondiabetic and diabetic detrusor and urothelial layer.

Authors:  Yi Wang; Gary G Deng; Kelvin P Davies
Journal:  Am J Physiol Endocrinol Metab       Date:  2016-06-28       Impact factor: 4.310

3.  Smooth muscle myosin expression, isoform composition, and functional activities in rat corpus cavernosum altered by the streptozotocin-induced type 1 diabetes.

Authors:  Xinhua Zhang; Nirmala D Kanika; Arnold Melman; Michael E DiSanto
Journal:  Am J Physiol Endocrinol Metab       Date:  2011-09-13       Impact factor: 4.310

Review 4.  Potential role of oxidative stress in the pathogenesis of diabetic bladder dysfunction.

Authors:  Qi-Xiang Song; Yi Sun; Kangli Deng; Jin-Yi Mei; Christopher J Chermansky; Margot S Damaser
Journal:  Nat Rev Urol       Date:  2022-08-16       Impact factor: 16.430

5.  Daidzein attenuates urinary bladder dysfunction in streptozotocin-induced diabetes in rats by NOX-4 and RAC-1 inhibition.

Authors:  Ankit P Laddha; Yogesh A Kulkarni
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2022-05-11       Impact factor: 3.195

6.  The effect of methamphetamine on an animal model of erectile function.

Authors:  M T Tar; L R Martinez; J D Nosanchuk; K P Davies
Journal:  Andrology       Date:  2014-04-03       Impact factor: 3.842

7.  Functional, morphological and molecular characterization of bladder dysfunction in streptozotocin-induced diabetic mice: evidence of a role for L-type voltage-operated Ca2+ channels.

Authors:  L O S Leiria; F Z T Mónica; F D G F Carvalho; M A Claudino; C F Franco-Penteado; A Schenka; A D Grant; G De Nucci; E Antunes
Journal:  Br J Pharmacol       Date:  2011-07       Impact factor: 8.739

Review 8.  Established and emerging treatments for diabetes-associated lower urinary tract dysfunction.

Authors:  Betül R Erdogan; Guiming Liu; Ebru Arioglu-Inan; Martin C Michel
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2022-05-12       Impact factor: 3.195

9.  Urothelial MaxiK-activity regulates mucosal and detrusor metabolism.

Authors:  Yi Wang; Gary G Deng; Kelvin P Davies
Journal:  PLoS One       Date:  2017-12-27       Impact factor: 3.240

10.  Time-dependent changes of erectile function in diabetic rats: role of systemic endothelial dysfunction.

Authors:  Woo Suk Choi; Kwanjin Park; Jae-Seung Paick; Soo Woong Kim
Journal:  World J Mens Health       Date:  2012-08-31       Impact factor: 5.400

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.